<< Back to all Blogs

Archives

Array
(
    [Jan 2012] => /2012/01/
    [Dec 2011] => /2011/12/
    [Nov 2011] => /2011/11/
    [Oct 2011] => /2011/10/
    [Sep 2011] => /2011/09/
    [Aug 2011] => /2011/08/
    [Jul 2011] => /2011/07/
)

My Blog Stats

Date Started: Jul 28, 2011
Entries: 558
Comments: 0
Total Visits: 29,682

Home > (ENZ, CYH, CVA, CLNO) Stock under Consideration by CRWEWallStreet.com

(ENZ, CYH, CVA, CLNO) Stock under Consideration by CRWEWallStreet.com

October 4th, 2011 at 01:59 pm

Enzo Biochem Inc. (ENZ)

Biotechnology helps to develop diverse pharmaceutical products for the treatment of wide range of human diseases. The examples include the development of human insulin to treat diabetes, human growth hormone, etc. Human genome sequencing project has paved the doorway to new therapeutic strategies.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21606

Posted in Investing | 0 Comments »

0 Responses to “(ENZ, CYH, CVA, CLNO) Stock under Consideration by CRWEWallStreet.com”

(Note: If you were logged in, we could automatically fill in these fields for you.)

Name:	*
Email:	Will not be published.
	Subscribe: Notify me of additional comments to this entry.
URL:
Verification:	* Please spell out the number 4. [ Why? ]

vB Code: You can use these tags: [b] [i] [u] [url] [email]

Wallstreet123's Personal Finance Blog

(ENZ, CYH, CVA, CLNO) Stock under Consideration by CRWEWallStreet.com

0 Responses to “(ENZ, CYH, CVA, CLNO) Stock under Consideration by CRWEWallStreet.com”

Leave a Reply